Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
611901 | ON 146040 | 1404231-34-0 | 98% | |
ON 146040 is the first dual PI3K and BCR-ABL inhibitor that targets the STAT3 and STA | ||||
161009007 | OSI-027 HCl salt | 936890-98-1 | 98% by HPLC | ![]() |
mTOR kinase inhibitor OSI-027 binds to and inhibits both the raptor-mTOR (TOR complex | ||||
16070915 | OtaMixaban | 193153-04-7 | 98% by HPLC | ![]() |
OtaMixaban | ||||
16070815 | Oritavancin | 171099-57-3 | 98% by HPLC | ![]() |
Oritavancin, also known as LY333328, is a novel semisynthetic glycopeptide antibiotic | ||||
1662310 | ON-01911.Na | 1330633-98-1(free base) | 98% by HPLC/HNMR | ![]() |
ON-01911.Na is a non-ATP-competitive inhibitor ofPLK1. | ||||
166215 | OSI-420(Desmethyl Erlotinib) | 183321-86-0 | 98% by HPLC | ![]() |
OSI-420 is the active metabolite of Erlotinib which is an orally active EGFR tyrosin | ||||
652602 | ONO4059-Analog | 1351635-67-0 | 98% by HPLC at 254nm | ![]() |
ONO4059-Analog(CAS#1351635-67-0)is a potent and selective BTK inhibitor. | ||||
42510 | Oritavancin(OC) | 192564-14-0 | 98% by HPLC at 254nm | ![]() |
Oritavancin (INN, also known as LY333328, Orbactiv) is a novel semisynthetic glycopep | ||||
123101 | ODM-201(BAY-1841788) | 1297538-32-9 | 98% by HPLC | ![]() |
ODM-201(also known as BAY-1841788)is a novel, nonsteroidal, orally active AR inhibito | ||||
121429 | Omipalisib(GSK2126458,GSK458) | 1086062-66-9 | 98% | ![]() |
GSK2126458 is a highly selective and potent inhibitor of PI3K with Ki of 0.019 nM/0.1 | ||||
120813 | O4I1 | 175135-47-4 | 98% | ![]() |
O4I1 is as a potent Oct3/4 inducer. | ||||
120812 | O4I2 | 165682-93-9 | 98% | ![]() |
O4I2 is a potent Oct3/4 inducer in various human cell lines including human fibroblas | ||||
120415 | Olanzapine | 132539-06-1 | 98% | ![]() |
Coming soon! | ||||
120413 | ozagrel | 82571-53-7 | 98% | ![]() |
Coming soon! | ||||
111012 | OTX015 | 202590-98-5 | 98% | ![]() |
OTX-015 is a new potent BRD2/3/4 inhibitor with evident anti-proliferative activity i | ||||
111006 | Otenabant | 686344-29-6 | 98% | ![]() |
Otenabant is a recently discovered selective, high affinity, competitive CB1 receptor | ||||
102609 | Optovin | 348575-88-2 | 98% | ![]() |
Optovin is a reversible photoactive TRPA1 activator; stimulates human TRPA1 channels | ||||
102603 | Otenabant Hydrochloride | 686347-12-6 | 98% | ![]() |
Otenabant Hcl (CP-945598) is a recently discovered selective, high affinity, competit | ||||
101918 | Oxaliplatin | 61825-94-3 | 98% | ![]() |
Coming soon! | ||||
101905 | Olodaterol | 868049-49-4 | 98% | ![]() |
Olodaterol is a long acting beta-adrenoceptor agonist used as an inhalation for treat | ||||
100901 | Omecamtiv mecarbil (CK-1827452) | 873697-71-3 | 98% | ![]() |
Omecamtiv mecarbil is a novel, small-molecule, direct activator of cardiac myosin, th | ||||
91416 | 3’-OMe Guanosine | 10300-27-3 | 98% by HPLC | ![]() |
3-OMe Guanosine CAS#10300-27-3 | ||||
91412 | 4-oxo-6-propan-2-ylchromene-3-carbonitrile | 50743-32-3 | 98% | ![]() |
The related API: AmoxanoxThe related intermediates: ethyl 2-amino-5-oxo-7-propan-2-yl | ||||
90110 | 5-Oxopyrrolidine-3-carboxamide | 14466-21-8 | 98% | ![]() |
Coming soon! | ||||
90103 | 1-O-benzyl 2-O-ethyl (2S)-5-oxopyrrolidine-1,2-dicarboxylate | 270065-52-6 | 98% | ![]() |
Coming soon! | ||||
90101 | 1-O-tert-butyl 2-O-methyl (2R)-pyrrolidine-1,2-dicarboxylate | 1190890-11-9 | 98% | ![]() |
Coming soon! | ||||
83132 | 1-O-tert-butyl 2-O-methyl (2R)-pyrrolidine-1,2-dicarboxylate | 73323-65-6 | 98% | ![]() |
Coming soon! | ||||
83131 | 1-O-tert-butyl 3-O-methyl (3S)-pyrrolidine-1,3-dicarboxylate | 313706-15-9 | 98% | ![]() |
Coming soon! | ||||
82722 | Omarigliptin intermediate 2 | 1280210-80-1 | 98% | ![]() |
Coming soon! | ||||
82718 | Omarigliptin intermediate I | 951127-25-6 | 98% | ![]() |
Coming soon! |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2025 Wuhan Sun-shine Bio-technology Corporation Limited. | 鄂ICP备17005301号-1